{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T10:52:10Z","timestamp":1792839130716,"version":"4.5.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,12]],"date-time":"2015-01-12T00:00:00Z","timestamp":1421020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.jhep.2015.01.003","type":"journal-article","created":{"date-parts":[[2015,4,22]],"date-time":"2015-04-22T01:45:43Z","timestamp":1429667143000},"page":"S121-S130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":223,"special_numbering":"S","title":["Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments"],"prefix":"10.1016","volume":"62","author":[{"given":"Jaume","family":"Bosch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto J.","family":"Groszmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay H.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2015.01.003_b0005","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jhep.2012.12.005","article-title":"The burden of liver disease in Europe: a review of available epidemiological data","volume":"58","author":"Blachier","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.01.003_b0010","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMra0901512","article-title":"Management of varices and variceal hemorrhage in cirrhosis","volume":"362","author":"Garcia-Tsao","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2015.01.003_b0015","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMoa044456","article-title":"Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis","volume":"353","author":"Groszmann","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2015.01.003_b0020","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/0016-5085(90)91168-6","article-title":"Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage","volume":"99","author":"Groszmann","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.01.003_b0025","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1053\/jhep.2003.50133","article-title":"Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis","volume":"37","author":"Abraldes","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.01.003_b0030","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrgastro.2009.149","article-title":"The clinical use of HVPG measurements in chronic liver disease","volume":"6","author":"Bosch","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2015.01.003_b0035","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2006.09.013","article-title":"Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review","volume":"131","author":"D\u2019Amico","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.01.003_b0040","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1572-0241.2006.00453.x","article-title":"Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis","volume":"101","author":"Turnes","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2015.01.003_b0045","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0002-9343(72)90188-X","article-title":"Quantitation of portasystemic shunting from the splenic and mesenteric beds in alcoholic liver disease","volume":"53","author":"Groszmann","year":"1972","journal-title":"Am J Med"},{"key":"10.1016\/j.jhep.2015.01.003_b0050","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0016-5085(19)33356-6","article-title":"Circulation times in the splanchnic and hepatic beds in alcoholic liver disease","volume":"63","author":"Kotelanski","year":"1972","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.01.003_b0055","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cld.2013.12.003","article-title":"Pharmacologic management of portal hypertension","volume":"18","author":"Berzigotti","year":"2014","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2015.01.003_b0060","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/S0168-8278(02)00430-0","article-title":"Current management of portal hypertension","volume":"38","author":"Bosch","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.01.003_b0065","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0140-6736(80)90063-X","article-title":"Propranolol \u2013 A medical treatment for portal hypertension?","volume":"2","author":"Lebrec","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2015.01.003_b0070","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0168-8278(85)80770-4","article-title":"Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators","volume":"1","author":"Bathal","year":"1985","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.01.003_b0075","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/hep.510280405","article-title":"Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats","volume":"28","author":"Gupta","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.01.003_b0080","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1172\/JCI116769","article-title":"Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo","volume":"92","author":"Rockey","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2015.01.003_b0085","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1053\/gast.2002.31040","article-title":"5-lipoxygenase inhibition reduces intrahepatic vascular resistance of cirrhotic rat livers: a possible role of cysteinyl-leukotrienes","volume":"122","author":"Graupera","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.01.003_b0090","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1053\/jhep.2003.50004","article-title":"Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers","volume":"37","author":"Graupera","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.01.003_b0095","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jhep.2007.01.020","article-title":"Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats","volume":"46","author":"Abraldes","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.01.003_b0100","doi-asserted-by":"crossref","unstructured":"De Gottardi A, Berzigotti A, Seijo S, D\u2019Amico M, Abraldes JG, Garcia-Pagan JC, et al. Dark chocolate attenuates the post-prandial increase in HVPG in patients with cirrhosis and portal hypertension., 52 ed.; 2010. p. S9.","DOI":"10.1016\/S0168-8278(10)60021-9"},{"key":"10.1016\/j.jhep.2015.01.003_b0105","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/hep.21080","article-title":"Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension","volume":"43","author":"Hernandez-Guerra","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.01.003_b0110","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/gut.2008.149880","article-title":"Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension","volume":"58","author":"Lavina","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2015.01.003_b0115","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hep.21228","article-title":"The eNOS cofactor tetrahydrobiopterin improves endothelial dysfunction in livers of rats with CCl4 cirrhosis","volume":"44","author":"Matei","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.01.003_b0120","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/hep.26520","article-title":"Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats","volume":"58","author":"Rosado","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.01.003_b0125","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1172\/JCI7997","article-title":"Gene transfer of the neuronal NO synthase isoform to cirrhotic rat liver ameliorates portal hypertension","volume":"105","author":"Yu","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2015.01.003_b0130","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1053\/j.gastro.2003.12.007","article-title":"Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis","volume":"126","author":"Zafra","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.01.003_b0135","doi-asserted-by":"crossref","first-page":"G757","DOI":"10.1152\/ajpgi.00017.2004","article-title":"Rat liver sinusoidal endothelial cell phenotype is maintained by paracrine and autocrine regulation","volume":"287","author":"DeLeve","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"3","key":"10.1016\/j.jhep.2015.01.003_b0140","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/hep.22351","article-title":"Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence","volume":"48","author":"DeLeve","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.01.003_b0145","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jhep.2012.08.026","article-title":"The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial-stellate cell deactivation induced by statins","volume":"58","author":"Marrone","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.01.003_b0150","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/hep.23478","article-title":"Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis","volume":"51","author":"Garcia-Tsao","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.01.003_b0155","first-page":"1238","article-title":"Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension","volume":"21","author":"Wanless","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.01.003_b0160","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1053\/j.gastro.2012.07.018","article-title":"Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis","volume":"143","author":"Villa","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.01.003_b0165","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.jhep.2014.05.047","article-title":"Vascular pathobiology in chronic liver disease and cirrhosis \u2013 Current status and future directions","volume":"61","author":"Iwakiri","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.01.003_b0170","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1172\/JCI119842","article-title":"Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in the hepatic sinusoids","volume":"100","author":"Shah","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2015.01.003_b0175","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jhep.2010.07.004","article-title":"Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension?","volume":"53","author":"Thabut","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.01.003_b0180","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/hep.510280405","article-title":"Endothelial dysfunction and Decreased Production of Nitric Oxide in the intrahepatic microcirculation of cirrhotic rats","volume":"28","author":"Gupta","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.01.003_b0185","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0016-5085(99)70408-7","article-title":"Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the Rat","volume":"117","author":"Shah","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.01.003_b0190","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jhep.2010.04.025","article-title":"Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells","volume":"53","author":"Trebicka","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.01.003_b0195","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1053\/j.gastro.2009.01.043","article-title":"Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial","volume":"136","author":"Abraldes","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.01.003_b0200","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jhep.2008.12.011","article-title":"Angiogenesis in liver disease","volume":"50","author":"Fernandez","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.01.003_b0205","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/hep.24129","article-title":"Noninvasive assessment of portal hypertension in patients with cirrhosis","volume":"53","author":"Thabut","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.01.003_b0210","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nature09493","article-title":"Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration","volume":"468","author":"Ding","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2015.01.003_b0215","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature12681","article-title":"Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis","volume":"505","author":"Ding","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2015.01.003_b0220","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.2353\/ajpath.2007.060887","article-title":"Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells","volume":"170","author":"Novo","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2015.01.003_b0225","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1053\/j.gastro.2014.01.061","article-title":"Vascular endothelial growth factor promotes fibrosis resolution and repair in mice","volume":"146","author":"Yang","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.01.003_b0230","article-title":"Liver sinusoidal endothelial cells in hepatic fibrosis","author":"DeLeve","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.01.003_b0235","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0016-5085(00)70368-4","article-title":"Angiotensin II induces contraction and proliferation of human hepatic stellate cells","volume":"118","author":"Bataller","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.01.003_b0240","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1053\/j.gastro.2006.01.038","article-title":"Toll-like receptor signaling in the liver","volume":"130","author":"Schwabe","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.01.003_b0245","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jhep.2011.11.013","article-title":"Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice","volume":"56","author":"Zhu","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.01.003_b0250","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/hep.23739","article-title":"Endothelial cell toll-like receptor 4 regulates fibrosis-associated angiogenesis in the liver","volume":"52","author":"Jagavelu","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.01.003_b0255","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGF-beta signaling and hepatic fibrosis","volume":"13","author":"Seki","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2015.01.003_b0260","doi-asserted-by":"crossref","first-page":"G838","DOI":"10.1152\/ajpgi.00151.2013","article-title":"HMGB1 recruits hepatic stellate cells and liver endothelial cells to sites of ethanol-induced parenchymal cell injury","volume":"305","author":"Seo","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2015.01.003_b0265","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jhep.2014.03.014","article-title":"Inflammation and portal hypertension \u2013 The undiscovered country","volume":"61","author":"Mehta","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.01.003_b0270","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1083\/jcb.127.6.2037","article-title":"Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis","volume":"127","author":"Jarnagin","year":"1994","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jhep.2015.01.003_b0275","doi-asserted-by":"crossref","first-page":"7190","DOI":"10.1074\/jbc.M111.304972","article-title":"Fibronectin induces endothelial cell migration through beta1 integrin and Src-dependent phosphorylation of fibroblast growth factor receptor-1 at tyrosines 653\/654 and 766","volume":"287","author":"Zou","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2015.01.003_b0280","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1478-3231.2010.02376.x","article-title":"Anticoagulation in cirrhosis patients: what don\u2019t we know?","volume":"31","author":"Northup","year":"2011","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.jhep.2015.01.003_b0285","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/hep.27387","article-title":"Chronic passive venous congestion drives hepatic fibrogenesis via sinusoidal thrombosis and mechanical forces","volume":"61","author":"Simonetto","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.01.003_b0290","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/j.gastro.2012.05.016","article-title":"Microparticles and paracrine signaling in portal hypertension: crucial conversations or idle chat?","volume":"143","author":"Garcia-Pagan","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.01.003_b0295","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1053\/j.gastro.2012.03.040","article-title":"Abnormal plasma microparticles impair vasoconstrictor responses in patients with cirrhosis","volume":"143","author":"Rautou","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.01.003_b0300","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/j.gastro.2008.09.066","article-title":"Liver cell-derived microparticles activate hedgehog signaling and alter gene expression in hepatic endothelial cells","volume":"136","author":"Witek","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.01.003_b0305","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/hep.510300124","article-title":"Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis","volume":"30","author":"Banares","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.01.003_b0310","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/hep.23689","article-title":"Carvedilol for portal hypertension in patients with cirrhosis","volume":"51","author":"Bosch","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.01.003_b0315","first-page":"269A","article-title":"Multicenter randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed","volume":"46","author":"Tripathi","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.01.003_b0320","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1172\/JCI102813","article-title":"The cardiac output at rest in Laennec cirrhosis","volume":"32","author":"Kowalski","year":"1953","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2015.01.003_b0325","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/hep.1840200538","article-title":"Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences","volume":"20","author":"Groszmann","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.01.003_b0330","series-title":"Arterial pressure and hypertension","author":"Guyton","year":"1980"},{"key":"10.1016\/j.jhep.2015.01.003_b0335","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1172\/JCI105545","article-title":"Portal blood flow in cirrhosis of the liver","volume":"46","author":"Moreno","year":"1967","journal-title":"J Clin Invest"},{"issue":"4 Suppl 2","key":"10.1016\/j.jhep.2015.01.003_b0340","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1097\/01.mcg.0000155552.14396.3d","article-title":"Portal hypertension: from bedside to bench","volume":"39","author":"Groszmann","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2015.01.003_b0345","first-page":"G618","article-title":"Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model","volume":"248","author":"Sikuler","year":"1985","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jhep.2015.01.003_b0350","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0016-5085(84)80072-4","article-title":"Increased blood flow through the portal system in cirrhotic rats","volume":"87","author":"Vorobioff","year":"1984","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.01.003_b0355","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1053\/jhep.2002.31432","article-title":"The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough","volume":"35","author":"Wiest","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.01.003_b0360","doi-asserted-by":"crossref","first-page":"G980","DOI":"10.1152\/ajpgi.00336.2005","article-title":"Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state","volume":"290","author":"Abraldes","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2015.01.003_b0365","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/0016-5085(93)90152-3","article-title":"Administration of N omega-nitro-L-arginine ameliorates portal-systemic shunting in portal-hypertensive rats","volume":"105","author":"Lee","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.01.003_b0370","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1053\/j.gastro.2013.06.036","article-title":"Activation of the MAS receptor by angiotensin-(1\u20137) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis","volume":"145","author":"Grace","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.01.003_b0375","article-title":"Molecular pathophysiology of portal hypertension","author":"Fernandez","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.01.003_b0380","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jhep.2014.03.014","article-title":"Inflammation and portal hypertension - the undiscovered country","volume":"61","author":"Mehta","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.01.003_b0385","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1053\/j.gastro.2003.12.012","article-title":"Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice","volume":"126","author":"Fernandez","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.01.003_b0390","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1056\/NEJM199512283332608","article-title":"Seminars in medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis","volume":"333","author":"Folkman","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2015.01.003_b0395","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/hep.26995","article-title":"Disruption of negative feedback loop between vasohibin-1 and vascular endothelial growth factor decreases portal pressure, angiogenesis, and fibrosis in cirrhotic rats","volume":"60","author":"Coch","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.01.003_b0400","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0016-5085(89)80090-3","article-title":"Endoscopic measurement of variceal pressure in cirrhosis: correlation with portal pressure and variceal hemorrhage","volume":"96","author":"Rigau","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.01.003_b0405","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.21785","article-title":"Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats","volume":"46","author":"Fernandez","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.01.003_b0410","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/hep.22758","article-title":"Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats","volume":"49","author":"Mejias","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.01.003_b0415","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1053\/gast.1997.v113.pm9352867","article-title":"Endoscopic assessment of variceal volume and wall tension in cirrhotic patients: effects of pharmacological therapy","volume":"113","author":"Escorsell","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.01.003_b0420","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1172\/JCI104497","article-title":"Determination of the hepatic arterial blood flow and oxygen supply in man by clamping the hepatic artery during surgery","volume":"41","author":"Tygstrup","year":"1962","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2015.01.003_b0425","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1113\/jphysiol.1967.sp008363","article-title":"The effect of haemorrhage on hepatic artery and portal vein flows in the anesthetized cat","volume":"193","author":"Greenway","year":"1967","journal-title":"J Physiol"},{"key":"10.1016\/j.jhep.2015.01.003_b0430","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00000658-197609000-00006","article-title":"Hepatic artery flow improvement after portacaval shunt: a single hemodynamic clinical correlate","volume":"184","author":"Burchell","year":"1976","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2015.01.003_b0435","first-page":"G507","article-title":"Compensatory mechanisms in response to an elevated hepatic oxygen consumption in chronically ethanol-fed rats","volume":"248","author":"Bredfeldt","year":"1985","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jhep.2015.01.003_b0440","doi-asserted-by":"crossref","first-page":"G197","DOI":"10.1152\/ajpgi.00190.2007","article-title":"The role of hepatic arterial flow on portal venous and hepatic venous wedged pressure in the isolated perfused CCl4-cirrhotic liver","volume":"295","author":"Zipprich","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2015.01.003_b0445","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jhep.2008.06.027","article-title":"Nitric oxide and vascular remodeling modulate hepatic arterial vascular resistance in the isolated perfused cirrhotic rat liver","volume":"49","author":"Zipprich","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.01.003_b0450","first-page":"H331","article-title":"Adenosine as putative regulator of hepatic arterial flow (the buffer response)","volume":"248","author":"Lautt","year":"1985","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jhep.2015.01.003_b0455","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/j.1478-3231.2010.02278.x","article-title":"A distinct nitric oxide and adenosine A1 receptor dependent hepatic artery vasodilatatory response in the CCl4-cirrhotic liver","volume":"30","author":"Zipprich","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2015.01.003_b0460","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","article-title":"Mechanisms of hepatic fibrogenesis","volume":"25","author":"Lee","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2015.01.003_b0465","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1002\/hep.20974","article-title":"Reversal of hepatic fibrosis \u2013 Fact or fantasy?","volume":"43","author":"Friedman","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.01.003_b0470","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jhep.2015.01.003_b0475","doi-asserted-by":"crossref","unstructured":"Abraldes JG, Villanueva C, Aracil C, Turnes J, Hernandez-Guerra M, Genesca J, et al. Addition of simvastatin to standard treatment improves survival after variceal bleeding in patients with cirrhosis. A double-blind randomized trial., 60 ed.; 2014. p. S525.","DOI":"10.1016\/S0168-8278(14)61462-8"},{"key":"10.1016\/j.jhep.2015.01.003_b0480","unstructured":"Amat-Roldan I, Berzigotti A, Gilabert R, Bosch J. Assessment of hepatic vascular network connectivity by automated graph analysis of dynamic contrast enhanced ultrasound to evaluate portal hypertension in patients with cirrhosis: a pilot study. Radiological society of North America 2014 scientific assembly and annual meeting, November 30-December 5, 2014, Chicago, IL:VSGI21-05."}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827815000069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827815000069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:55:16Z","timestamp":1598921716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827815000069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0168827815000069"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2015.01.003","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2015.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 European Association for the Study of the Liver. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}